Applications of Polymers in Dentifrices and Mouthrinses

Journal of Clinical Dentistry

Volumn 13, Issue 4, 2002, Pages 138-148

  Gaffar, Abdul ^a   Hunter, Catherine M ^a   Mirajkar, Yelloji Rao K ^a  

^a Technology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORIDE VARNISH; POLYMER; SALIVA SUBSTITUTE; TOOTHPASTE; TOPICAL ANTIINFECTIVE AGENT;

ANIMAL; BACTERIUM ADHERENCE; CHEMISTRY; DENTAL CARIES; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; MOUTH HYGIENE; REVIEW; TOOTH CALCULUS;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL ADHESION; DENTAL CARIES; DENTAL DEPOSITS; DENTIFRICES; DRUG DELIVERY SYSTEMS; FLUORIDES, TOPICAL; HUMANS; MOUTHWASHES; POLYMERS; SALIVA, ARTIFICIAL;

EID: 0036047577     PISSN: 08958831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Lipatova TE: Medical polymer adhesives. Adv Poly Sci 79:65, 1986.
2. Anbar M, Neivel GW, St. John GA: Fate and toxicity of orally administered polyethylene polyphosphonates. Fd Cosmet Toxicol 2:1001-1010, 1973.
3. 14] polyvinyl phosphonic acid. J Lab Compounds 27:647-652, 1989.
4. Gaffar A, Moreno E, Afflitto J, Mirajkar YR: Crystal growth of hydroxyapatite in vitro and dental calculus and plaque formation in human teeth in vivo. In: Water Soluble Polymers, Amjad Z, ed., Plum Press, NY, pp. 91-104, 1998.
5. Technical Bulletin. ISSP. Wayne, NJ, 1989.
6. Gaffar A, Blake-Haskins JC, Sullivan R, Simone A, Schmidt R, Saunders F: Cariostatic effect of xylitol/fluoride dentifrice in vivo. Int Dent J 48:32-39, 1998.
7. Fluoride conference report: Mechanism of action and recommendations for use. J Dent Res 69:507-676, 1999.
8. Retief DH, Bradley EL, Holbrook M, Switzer P: Enamel fluoride uptake, distribution and retention from topical fluoride agents. Caries Res 17:44-51, 1983.
9. Schmidt VHF: Ein neues tauchierungsmitel mit besonders lang anhaltendem intensivem fluoridierungseffekt. Stoma 17:14-20, 1964.
10. Shobha T, Nandalal B, Prabhakar AR, Sudha P: Fluoride varnish vs. acidulated phosphate fluoride for children in Manipab. J Int Dent Assoc 59:157-160, 1987.
11. Zhang YP, Sullivan RJ, Din C, Gaffar A: Anticaries effect of a triclosan/copolymer/ NaF dentifrice in vivo. ADA/FDI Congress Proceedings 136, 1996.
12. Furuichi Y, Birkhed D: Retention of fluoride/triclosan/copolymer in plaque following different mode of administration. J Clin Periodontol 26:14-18, 1999.
13. Zhang YP, Din CS, Nathoo S, Miller S, Gaffar A: Improved intra-oral remineralization of MFP/DCPD vs. MFP/Silica, Int Dent J 45:322, 1995.
14. Anbar M, St. John GD. Adsorption of polyphosphonated polyethyl on enamel of teeth. J Dent Res 3:778, 1997.
15. th Ed. W.B. Saunders Co., Philadelphia, 1986.
16. Muhlemann HR, Strub JR: Inhibition of plaque growth with taurolin, ventocil and amine fluoride. Helv Odont Acta 19:57-60, 1975.
17. Schmid R, Afflitto J, Gaffar A: Cariostatic effects of monofluorophosphate in solutions and dentifrices in rats. J Clin Dent 63:75-82, 1989.
18. Anbar M, St. John GA, Edward TE: Organic polymeric polyphosphonates as potential preventive agents of dental caries. J Dent Res 53:1240-1244, 1973.
19. Onisi M, Ozaki F, Yoshino F, Murakama Y: An experimental evidence of caries preventive activity of non-fluoride component of tea. J Dent Health 31:158, 1981.
20. Reynolds EC, Riley OF, Storey E: Phosphoprotein inhibition of hydroxyapatite dissolution. Cal Tissue Int 34:552-56, 1982.
21. Reynolds EC, Del Rio A: Effects of casein and whey protein solutions on caries experience and feeding patterns on the rat. Arch Oral Biol 29:927-33, 1984.
22. Reynolds EC: The prevention subsurface demineralization of bovine enamel and change in plaque composition by casein in an intra-oral model. J Dent Res 66:1120-1127, 1987.
23. Roberts AJ, Taylor CA, Littlewood DT, Horay CP: Anticaries mode of action of casein-derived phosphopeptides. J Dent Res 73:385, 1994.
24. Gaffar A, Legeros RZ, Gambogi R, Afflitto J: Inhibition of formation of calcium phosphate deposits on teeth and dental materials: Recent advances. Adv Dent Res 9:419-426, 1995.
25. Gaffar A: Chemical tartar control technology. Cosmet Toiletries 107:73-78, 1992.
26. Gaffar A, Polefka T, Afflitto J, Esposito A, Smith S: In vitro evaluation of pyrophosphate/copolymer/NaF as anticalculus agent. Compend Cont Ed Dent 8:S242-S255, 1986.
27. Gaffar A, Schmid R, Afflitto J, Coleman E: Effects of pyrophosphate/copolymer/NaF on dental calculus and caries in vivo. Compend Cont Educ Dent 8:S251-S255, 1987.
28. Gaffar A, Toba T, Afflitto J, Moreno EC: Structure-activity relationship between in vitro inhibition of HA crystal growth and in vivo anticalculus effects. In: Recent Advances in the Study of Dental Calculus, ten Cate JM, ed., IRS Press, Maclean, VA, pp. 155-171, 1989.
29. Volpe AR, Petrone M, Davies RM: A review of calculus clinical efficacy studies. J Clin Dent 4:71-81, 1993.
30. Gaffar A, Niles HP, Davis CB: Evaluation of oligomer or an oligomer plus cetylpyridinium chloride against plaque, stain, calculus, and gingivitis. J Dent Res 60:1432-1439, 1981.
31. Gibbons RJ, Van Haute H: Bacterial adherence and the formation of dental plaque. In: Bacterial Adherence, Receptors and Recognition, Beasley EH, ed., Chapman Hall, London, 1980.
32. Kolenbrander PE, Ganeshkuma N, Cassels FJ, Hughes CV: Coaggregation: Specific adherence among human oral plaque bacteria. FASFBJ 7:406-413, 1993.
33. Gaffar A, Esposito T, Bahl M, Steinberg T, Mandel I: Interactions of perfluoroalkyl surfactants to teeth in vitro and in vivo. Colloids and Surfaces 26:109-121, 1983.
34. Stromberg N, Boren T, Dahlen G, Lindhe J, Sandros J: Synthetic receptor analogues prevent plaque formation in man. J Dent Res 71:4-1078, 1992.
35. Stromberg N, Boren T: Actinomyces tissue specificity may depend on differences for GALNAcB containing glucoconjugates. Infect Immunol 80:3268-3277, 1992.
36. Nesser J-R, Chamba A, Vedoro SP, Prigent M-J, Guggenheim B: Specific and non-specific inhibition of adhesion of oral actinomyces and streptococci to erythrocytes and polystyrene by caseinoglycopeptide derivative. Infect Immunol 56:3201-3208, 1988.
37. Gaffar A, Afflitto J, Nabi N, Herles S, Kruger I, Olsen S: Recent advances in plaque, gingivitis, tartar and caries prevention technology. Int Dent J 44:63-70, 1994.
38. Volpe AR, Petrone ME, DeVizio W, Davies RM: A review of plaque, gingivitis, calculus and caries clinical efficacy studies with a dentifrice containing triclosan and PVM/MA copolymer. J Clin Dent 4:31-39, 1995.
39. Allen DR, Battista GW, Petrone DM, Petrone ME, Chaknis P, DeVizio W, Volpe AR: The clinical efficacy of Colgate Total Plus Whitening Toothpaste containing a special grade of silica and Colgate Total Fresh Stripe Toothpaste in the control of plaque and gingivitis: A six-month clinical study. J Clin Dent 13:59-64, 2002.
40. Nabi N, Kashuba B, Lucchesi S, Afflitto J, Furuichi Y, Gaffar A: In vitro and in vivo studies on salifluor/PVM/MA copolymer/NaF combination as an antiplaque agent. J Clin Periodontol 23:1084-1092, 1996.
41. Woods GL, Washington JA: Antibacterial susceptibility tests: Dilution and disk diffusion methods, In: Manual of Clinical Microbiology, Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds., ASM Press, Washington, pp. 1327-1341, 1995.
42. Gaffar A, Nabi N, Kashuba B, Williams M, Herles S, Olsen S, Afflitto J: Antiplaque effects of dentifrices containing triclosan/copolymer/NaF system vs. dentifrices without copolymer. Am J Dent 3:S7-S14, 1990.
43. Mirajkar YK, Unpublished data, 1998.
44. Nabi N, Mukerjee C, Schmid R, Gaffar G: In vitro and in vivo studies on triclosan/PVM/MA/NaF combination as an antiplaque agent. Am J Dent 2: 197-206, 1989.
45. Herles S, Olsen S, Afflitto J, Gaffar A: Chemostat flow cell system: An in vitro model for the valuation of antiplaque agents. J Dent Res 73:1748-1755, 1994.
46. Korstanje MJ: Drug-induced mouth disorders. Clin Exp Derm 20:10-18, 1995.
47. Sreebny LM, Schwartz SS: A reference guide to drugs and dry mouth. Gerodont 5:75-99, 1986.
48. Sreebny LM: Xerostomia: A neglected system. Arch Intern Med 147:1333-1337, 1987.
49. Olsson H, Axell T, Carlsson A, Bogentoft C: Objective and subjective efficacy evaluation of various polymer-based saliva substitutes. Scand J Dent Res 101:37-39, 1993.
50. van der Reijden WA, Van Der Kwaak H, Vissink A, Veerman ECI, Nieuw Amerongen AV: Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome. Arth Rheumat 39:57-63, 1996.
51. van der Reijden WA, Veerman ECI, Nieuw Amerongen AV: Rheological properties of commercially available polysaccharides with potential use in saliva substitutes. Biorheol 31:631-642, 1994.
52. Vissink A, Waterman HA, Gravenmade EJ, Panders AK, Verney A: Rheological properties of saliva substitutes containing mucin, carboxymethyl-cellulose or polyethyleneoxide. J Oral Pathol 13:22-28, 1984.
53. Hatton MN, Levine MJ, Margarone JE, Aguirre A: Lubrication and viscosity features of human saliva and commercially available saliva substitutes. J Oral Maxillofac Surg 45:496-499, 1987.
54. Levine MJ, Aguirre A, Hatton MN, Tabak LA: Artificial salivas: Present and future. J Dent Res 66:693-398, 1987.
55. Mellema J, Holterman HJ, Waterman HA, Blom C, Gravenmade EJ: Rheological aspects of mucin-containing solutions and saliva substitutes. Biorheol 29:231-249, 1992.
56. Schwartz WH: The rheology of saliva. J Dent Res 66:660-664, 1987.
57. van der Reijden WA, Veerman ECI, Nieuw Amerongen AV: Shear rate dependent viscoelastic behavior of human glandular salivas. Biorheol 30:141-152, 1993.
58. Ciba Specialty Chemicals Inc. product information: Tinocare GL. 1998.
59. Hunter CM, Mordarski CM: Unpublished data, 2001.